BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18284428)

  • 21. Tau is a candidate gene for chromosome 17 frontotemporal dementia.
    Poorkaj P; Bird TD; Wijsman E; Nemens E; Garruto RM; Anderson L; Andreadis A; Wiederholt WC; Raskind M; Schellenberg GD
    Ann Neurol; 1998 Jun; 43(6):815-25. PubMed ID: 9629852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features.
    Ikeda A; Shimada H; Nishioka K; Takanashi M; Hayashida A; Li Y; Yoshino H; Funayama M; Ueno Y; Hatano T; Sahara N; Suhara T; Higuchi M; Hattori N
    Mov Disord; 2019 Apr; 34(4):568-574. PubMed ID: 30773680
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau.
    Tatebayashi Y; Miyasaka T; Chui DH; Akagi T; Mishima K; Iwasaki K; Fujiwara M; Tanemura K; Murayama M; Ishiguro K; Planel E; Sato S; Hashikawa T; Takashima A
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13896-901. PubMed ID: 12368474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin.
    Mukherjee O; Pastor P; Cairns NJ; Chakraverty S; Kauwe JS; Shears S; Behrens MI; Budde J; Hinrichs AL; Norton J; Levitch D; Taylor-Reinwald L; Gitcho M; Tu PH; Tenenholz Grinberg L; Liscic RM; Armendariz J; Morris JC; Goate AM
    Ann Neurol; 2006 Sep; 60(3):314-22. PubMed ID: 16983685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerated filament formation from tau protein with specific FTDP-17 missense mutations.
    Nacharaju P; Lewis J; Easson C; Yen S; Hackett J; Hutton M; Yen SH
    FEBS Lett; 1999 Mar; 447(2-3):195-9. PubMed ID: 10214944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Search for a mutation in the tau gene in a Swiss family with frontotemporal dementia.
    Savioz A; Kövari E; Anastasiu R; Rossier C; Saini K; Bouras C; Leuba G
    Exp Neurol; 2000 Jan; 161(1):330-5. PubMed ID: 10683298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PET of brain amyloid and tau in mild cognitive impairment.
    Small GW; Kepe V; Ercoli LM; Siddarth P; Bookheimer SY; Miller KJ; Lavretsky H; Burggren AC; Cole GM; Vinters HV; Thompson PM; Huang SC; Satyamurthy N; Phelps ME; Barrio JR
    N Engl J Med; 2006 Dec; 355(25):2652-63. PubMed ID: 17182990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tau negative frontal lobe dementia at 17q21: significant finemapping of the candidate region to a 4.8 cM interval.
    Rademakers R; Cruts M; Dermaut B; Sleegers K; Rosso SM; Van den Broeck M; Backhovens H; van Swieten J; van Duijn CM; Van Broeckhoven C
    Mol Psychiatry; 2002; 7(10):1064-74. PubMed ID: 12476321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frontotemporal lobar degeneration with MAPT mutation in an Italian-Polish family. A case report.
    Wierzba-Bobrowicz T; Lewandowska E; Zaremba J; Berdyński M; Żekanowski C; Stępień T; Felczak P; Tarka S
    Folia Neuropathol; 2014; 52(4):457-66. PubMed ID: 25574752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation).
    Arvanitakis Z; Witte RJ; Dickson DW; Tsuboi Y; Uitti RJ; Slowinski J; Hutton ML; Lin SC; Boeve BF; Cheshire WP; Pooley RA; Liss JM; Caviness JN; Strongosky AJ; Wszolek ZK
    Parkinsonism Relat Disord; 2007 May; 13(4):230-9. PubMed ID: 17196872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation.
    Boeve BF; Tremont-Lukats IW; Waclawik AJ; Murrell JR; Hermann B; Jack CR; Shiung MM; Smith GE; Nair AR; Lindor N; Koppikar V; Ghetti B
    Brain; 2005 Apr; 128(Pt 4):752-72. PubMed ID: 15615814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypic heterogeneity within a new family with the MAPT p301s mutation.
    Yasuda M; Nakamura Y; Kawamata T; Kaneyuki H; Maeda K; Komure O
    Ann Neurol; 2005 Dec; 58(6):920-8. PubMed ID: 16240366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia.
    Momeni P; Wickremaratchi MM; Bell J; Arnold R; Beer R; Hardy J; Revesz T; Neal JW; Morris HR
    Clin Neurol Neurosurg; 2010 Dec; 112(10):917-20. PubMed ID: 20708332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TAU haplotype and the Saitohin Q7R gene polymorphism do not influence CSF Tau in Alzheimer's disease and are not associated with frontotemporal dementia or Parkinson's disease.
    Johansson A; Zetterberg H; Håkansson A; Nissbrandt H; Blennow K
    Neurodegener Dis; 2005; 2(1):28-35. PubMed ID: 16909000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions.
    Wilhelmsen KC; Forman MS; Rosen HJ; Alving LI; Goldman J; Feiger J; Lee JV; Segall SK; Kramer JH; Lomen-Hoerth C; Rankin KP; Johnson J; Feiler HS; Weiner MW; Lee VM; Trojanowski JQ; Miller BL
    Arch Neurol; 2004 Mar; 61(3):398-406. PubMed ID: 15023818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular genetics of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
    Kowalska A
    Folia Neuropathol; 2002; 40(3):111-8. PubMed ID: 12572916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Molecular analysis of tau deposited in the FTDP-17 brain].
    Morishima-Kawashima M
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1107-10. PubMed ID: 12235810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of tau (MAPT) in frontotemporal dementia and related tauopathies.
    Rademakers R; Cruts M; van Broeckhoven C
    Hum Mutat; 2004 Oct; 24(4):277-95. PubMed ID: 15365985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, neuropathological, and biochemical characterization of the novel tau mutation P332S.
    Deramecourt V; Lebert F; Maurage CA; Fernandez-Gomez FJ; Dujardin S; Colin M; Sergeant N; Buée-Scherrer V; Clot F; Ber IL; Brice A; Pasquier F; Buée L
    J Alzheimers Dis; 2012; 31(4):741-9. PubMed ID: 22699846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinsonism and distinct dementia patterns in a family with the MAPT R406W mutation.
    Carney RM; Kohli MA; Kunkle BW; Naj AC; Gilbert JR; Züchner S; Pericak-Vance MA
    Alzheimers Dement; 2014 May; 10(3):360-5. PubMed ID: 23727082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.